Prostaglandin E2

Prostaglandin E2 is a lipid of Fatty Acyls (FA) class. Prostaglandin e2 is associated with abnormalities such as Renal glomerular disease, Arthritis, Degenerative polyarthritis, Pancreatitis and Rheumatoid Arthritis. The involved functions are known as enzyme pathway, Atherogenesis, Anabolism, inhibitors and Oxidants. Prostaglandin e2 often locates in Tissue membrane, Blood, Extracellular, Membrane and Protoplasm. The associated genes with Prostaglandin E2 are PTGS2 gene, TP53 gene, TNFRSF5 gene, FASTK Gene and TNF gene. The related lipids are Lipopolysaccharides, Steroids, monooxyethylene trimethylolpropane tristearate, Fatty Acids, Unsaturated and Promega. The related experimental models are Arthritis, Adjuvant-Induced, Xenograft Model, Experimental Autoimmune Encephalomyelitis, Cancer Model and Knock-out.

References related to abnormalities published in Eur. J. Pharmacol.


PMIDJournalPublished DateAuthorTitle
21147091Eur. J. Pharmacol.2011Wu F et al.Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells.
16624280Eur. J. Pharmacol.2006Guo JY et al.Cinnamaldehyde reduces IL-1beta-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells.
14751415Eur. J. Pharmacol.2004Warzecha Z et al.Inhibition of cyclooxygenase-2 reduces the protective effect of hepatocyte growth factor in experimental pancreatitis.
28322839Eur. J. Pharmacol.2017Spindola HM et al.Derivatives of furanditerpenes from Pterodon genus: Pharmacological studies disclose their potential as chronic pain relief in mice.
27108790Eur. J. Pharmacol.2016Rumzhum NN and Ammit AJProstaglandin E2 induces expression of MAPK phosphatase 1 (MKP-1) in airway smooth muscle cells.
26607459Eur. J. Pharmacol.2015Root JA et al.Prostanoid receptors mediating contraction in rat, macaque and human bladder smooth muscle in vitro.
26415983Eur. J. Pharmacol.2015Li Y et al.Regulation of PGE2 signaling pathways and TNF-alpha signaling pathways on the function of bone marrow-derived dendritic cells and the effects of CP-25.
26162701Eur. J. Pharmacol.2015Zhang H et al.Anti-inflammatory effects of farrerol on IL-1β-stimulated human osteoarthritis chondrocytes.
25064339Eur. J. Pharmacol.2014Wei H et al.Doliroside A attenuates monosodium urate crystals-induced inflammation by targeting NLRP3 inflammasome.
24943733Eur. J. Pharmacol.2014Shabbir A et al.Anti-arthritic activity of N'-[(2,4-dihydroxyphenyl)methylidene]-2-(3,4-dimethyl-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-1(4H)-yl)acetohydrazide.
24211328Eur. J. Pharmacol.2013Magnone M et al.Fluridone as a new anti-inflammatory drug.
22713546Eur. J. Pharmacol.2012Hsu YH et al.Long-term leptin treatment exerts a pro-apoptotic effect on renal tubular cells via prostaglandin E2 augmentation.
22575522Eur. J. Pharmacol.2012Lee JH et al.Prevention effects of ND-07, a novel drug candidate with a potent antioxidative action and anti-inflammatory action, in animal models of severe acute pancreatitis.
20361960Eur. J. Pharmacol.2010Zrieki A et al.Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo.
18448096Eur. J. Pharmacol.2008Nieminen R et al.Aurothiomalate inhibits COX-2 expression in chondrocytes and in human cartilage possibly through its effects on COX-2 mRNA stability.
18325491Eur. J. Pharmacol.2008Grinshpun J et al.Differential regulation of prostaglandin synthesis in neonatal rat microglia and astrocytes by somatostatin.
18207140Eur. J. Pharmacol.2008Mrnka L et al.Melatonin inhibits prostaglandin E2- and sodium nitroprusside-induced ion secretion in rat distal colon.
17543298Eur. J. Pharmacol.2007Chuang YH et al.Cyclooxygenase-2 inhibitor ameliorates ureteric damage in rats with obstructed uropathy.
17316604Eur. J. Pharmacol.2007Rowland SE et al.Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species.
17258197Eur. J. Pharmacol.2007Nakano M et al.Interaction between cyclooxygenase (COX)-1- and COX-2-products modulates COX-2 expression in the late phase of acute inflammation.
16405885Eur. J. Pharmacol.2006Hougee S et al.Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice.
15840408Eur. J. Pharmacol.2005Takahashi HK et al.Differential effect of prostaglandins E1 and E2 on lipopolysaccharide-induced adhesion molecule expression on human monocytes.
15680249Eur. J. Pharmacol.2005Zacharowski P et al.NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
15363968Eur. J. Pharmacol.2004Brzozowski T et al.Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves.
11090649Eur. J. Pharmacol.2000Thapaliya S et al.Bradykinin causes endothelium-independent hyperpolarisation and neuromodulation by prostanoid synthesis in hamster mesenteric artery.
10729362Eur. J. Pharmacol.2000Koyama A et al.Nitric oxide accelerates the ascorbic acid-induced osteoblastic differentiation of mouse stromal ST2 cells by stimulating the production of prostaglandin E(2).
10594346Eur. J. Pharmacol.1999Yamada R et al.Auranofin inhibits interleukin-1beta-induced transcript of cyclooxygenase-2 on cultured human synoviocytes.
10422646Eur. J. Pharmacol.1999Marquet F et al.Distant intestinal stimulation by cholera toxin in rat in vivo.
9671112Eur. J. Pharmacol.1998Zamora R et al.The role of prostaglandin E2 and nitric oxide in cell death in J774 murine macrophages.
9600662Eur. J. Pharmacol.1998Niki H et al.Effects of JTE-522, a specific inhibitor of cyclooxygenase-2, on the recurrence of allergic inflammation in rats.
9544793Eur. J. Pharmacol.1998Konturek PC et al.Activation of genes for growth factors and cyclooxygenases in rat gastric mucosa during recovery from stress damage.